C-reactive protein down-regulates endothelial nitric oxide synthase expression and promotes apoptosis in endothelial progenitor cells through receptor for advanced glycation end-products

Gene

Volumn 496, Issue 2, 2012, Pages 128-135

  Chen, Jianfei ^a   Jin, Jun ^a   Song, Minbao ^a   Dong, Hongmei ^a   Zhao, Gan ^a   Huang, Lan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; C reactive protein; Endothelial nitric oxide synthase; Endothelial progenitor cells; Receptor for advanced glycation end products

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADVANCED GLYCATION END PRODUCT RECEPTOR; C REACTIVE PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LIPOCORTIN 5; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROPHOTOMETRY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; BONE MARROW CELLS; C-REACTIVE PROTEIN; CELL MOVEMENT; DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION END PRODUCTS, ADVANCED; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS;

EID: 84862817321     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.12.039     Document Type: Article

References (28)

1. Verma S., Deraraj S., Jialal I. Is C-reactive protein an innocent bystander or proactive culprit? C-reactive protein promotes atherothrombosis. Circulation 2006, 113:2135-2150.
2. Corrado E., Rizzo M., Coppola G., et al. An update on the role of markers of inflammation in atherosclerosis. J. Atheroscler. Thromb. 2010, 17(1):1-11.
3. Chen J., Huang L., Song M., Yu S., Gao P., Jing J. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells. J. Cardiovasc. Pharmacol. 2009, 53(5):359-367.
4. Bierhaus A., Humpert P.M., Morcos M., et al. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 2005, 83(11):876-886.
5. Ramasamy R., Yan S.F., Schmidt A.M. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond. Trends Cardiovasc. Med. 2005, 15(7):237-243.
6. Chavakis E., Hain A., Vinci M., et al. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ. Res. 2007, 100(2):204-212.
7. Ii M., Takeshita K., Ibusuki K., et al. Notch signaling regulates endothelial progenitor cell activity during recovery from arterial injury in hypercholesterolemic mice. Circulation 2010, 121(9):1104-1112.
8. Van Craenenbroeck E.M., Conraads V.M. Endothelial progenitor cells in vascular health: focus on lifestyle. Microvasc. Res. 2010, 79(3):184-192.
9. Tousoulis D., Andreou I., Antoniades C., Tentolouris C., Stefanadis C. Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases. Atherosclerosis 2008, 201(2):236-247.
10. Huang P.H., Chen Y.H., Tsai H.Y., et al. Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler. Thromb. Vasc. Biol. 2010, 30(4):869-877.
11. Patschan D., Patschan S., Henze E., Wessels J.T., Koziolek M., Müller G.A. LDL lipid apheresis rapidly increases peripheral endothelial progenitor cell competence. J. Clin. Apher. 2009, 24(5):180-185.
12. Ota H., Eto M., Ogawa S., Iijima K., Akishita M., Ouchi Y. SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis. J. Atheroscler. Thromb. 2010, 17(5):431-435.
13. Muller G., Morawietz H. Nitric oxide, NAD(P)H oxidase, and atherosclerosis. Antioxid. Redox Signal. 2009, 11(7):1711-1731.
14. Werner N., Junk S., Laufs U., et al. 2003 Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ. Res. 2003, 93(2):e17-e24. (Jul 25).
15. Chen J., Song M., Yu S., et al. Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress. Mol. Cell. Biochem. 2010, 335(1-2):137-146.
16. Hill J.M., Zalos G., Halcox J.P.J., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 2003, 348:593-600.
17. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 2005, 353:999-1007.
18. Umemura T., Higashi Y. Endothelial progenitor cells: therapeutic target for cardiovascular diseases. J. Pharmacol. Sci. 2008, 108(1):1-6.
19. Sambuceti G., Morbelli S., Vanella L., et al. Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage, reversed by increases in pAMPK, heme oxygenase-1, and adiponectin. Stem Cells 2009, 27(2):399-407.
20. Jandeleit-Dahm K., Watson A., Soro-Paavonen A. The AGE/RAGE axis in diabetes-accelerated atherosclerosis. Clin. Exp. Pharmacol. Physiol. 2008, 35(3):329-334.
21. Ramasamy R., Yan S.F., Herold K., Clynes R., Schmidt A.M. Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis. Ann. N. Y. Acad. Sci. 2008, 1126:7-13. (Apr).
22. Kawashima S., Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2004, 24(6):998-1005.
23. Lazar H.L., Joseph L., San Mateo C., et al. Expression of inducible nitric oxide synthase in conduits used in patients with diabetes mellitus undergoing coronary revascularization. J. Card. Surg. 2010, 25(1):120-126.
24. de Haro Miralles J., Martínez-Aguilar E., Florez A., Varela C., Bleda S., Acin F. Nitric oxide: link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbs. Interact. Cardiovasc. Thorac. Surg. 2009, 9(1):107-112.
25. Hein T.W., Singh U., Vasquez-Vivar J., Devaraj S., Kuo L., Jialal I. Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis 2009, 206(1):61-68.
26. Teoh H., Quan A., Lovren F., et al. Impaired endothelial function in C-reactive protein overexpressing mice. Atherosclerosis 2008, 201(2):318-325.
27. Fujii H., Li S.H., Szmitko P.E., Fedak P.W., Verma S. C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 2006, 26(11):2476-2482.
28. Rauscher F.M., Goldschmidt P.J., Davis B.H., et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003, 108(4):457-463.